Photochemical internalization (PCI) of HER2-targeted toxins: Synergy is dependent on the treatment sequence

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 12, 2012, Pages 1849-1858

  Berstad, Maria Brandal ^a   Weyergang, Anette ^a   Berg, Kristian ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Human epidermal growth factor receptor 2; Immunotoxin; Photochemical; Photodynamic therapy; Saporin; Trastuzumab

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOTOXIN; SAPORIN; TRASTUZUMAB;

ARTICLE; CELL MEMBRANE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; LD 50; LIGHT EXPOSURE; PHOTOCHEMICAL INTERNALIZATION; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING;

ANTIBODIES, MONOCLONAL, HUMANIZED; BLOTTING, WESTERN; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ENDOCYTOSIS; FEMALE; HUMANS; IMMUNOTOXINS; LIGHT; PHOSPHORYLATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RECEPTOR, ERBB-2; RIBOSOME INACTIVATING PROTEINS, TYPE 1; TUMOR CELLS, CULTURED;

EID: 84866546285     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2012.08.027     Document Type: Article

References (58)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2893 2917
2. T. Sorlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M.B. Eisen, R.M. van de, S.S. Jeffrey, T. Thorsen, H. Quist, J.C. Matese, P.O. Brown, D. Botstein, L.P. Eystein, and A.L. Borresen-Dale Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc. Natl. Acad. Sci. U. S. A. 98 2001 10869 10874
3. Y. Tokuda, Y. Suzuki, Y. Saito, and S. Umemura The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review Breast Cancer 16 2009 295 300
4. A. Brufsky Trastuzumab-based therapy for patients with HER2-positive breast cancer: from early scientific development to foundation of care Am. J. Clin. Oncol. 33 2010 186 195
5. H. Mukai Treatment strategy for HER2-positive breast cancer Int. J. Clin. Oncol. 15 2010 335 340
6. K. Berg, P.K. Selbo, L. Prasmickaite, T.E. Tjelle, K. Sandvig, J. Moan, G. Gaudernack, O. Fodstad, S. Kjolsrud, H. Anholt, G.H. Rodal, S.K. Rodal, and A. Hogset Photochemical internalization: a novel technology for delivery of macromolecules into cytosol Cancer Res. 59 1999 1180 1183
7. Phase I, Dose-escalating Study to Evaluate Safety and Tolerance of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients with Local Recurrence or Advanced/Metastatic, Cutaneous or Sub-cutaneous Malignancies NCT00993512 2011
8. P. Agostinis, K. Berg, K.A. Cengel, T.H. Foster, A.W. Girotti, S.O. Gollnick, S.M. Hahn, M.R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B.C. Wilson, and J. Golab Photodynamic therapy of cancer: an update CA Cancer J. Clin. 61 2011 250 281
9. A. Weyergang, P.K. Selbo, and K. Berg Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin J. Control. Release 111 2006 165 173
10. W.L. Yip, A. Weyergang, K. Berg, H.H. Tonnesen, and P.K. Selbo Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells Mol. Pharm. 4 2007 241 251
11. P.K. Selbo, G. Sivam, O. Fodstad, K. Sandvig, and K. Berg Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin Int. J. Cancer 87 2000 853 859
12. P.K. Selbo, M.G. Rosenblum, L.H. Cheung, W. Zhang, and K. Berg Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel PLoS One 4 2009 e6691
13. K. Eiklid, S. Olsnes, and A. Pihl Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells Exp. Cell Res. 126 1980 321 326
14. A. Weyergang, P.K. Selbo, M.E.B. Berstad, M. Bostad, and K. Berg Photochemical internalization of tumor-targeted protein toxins Lasers Surg. Med. 43 2011 721 733
15. B.S. Hendriks, L.K. Opresko, H.S. Wiley, and D. Lauffenburger Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects Cancer Res. 63 2003 1130 1137
16. G. Cavalloni, I. Sarotto, Y. Pignochino, L. Gammaitoni, G. Migliardi, L. Sgro, W. Piacibello, M. Risio, M. Aglietta, and F. Leone Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab Anticancer Drugs 19 2008 689 696
17. L. Prasmickaite, A. Hogset, P.K. Selbo, B.O. Engesaeter, M. Hellum, and K. Berg Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy Br. J. Cancer 86 2002 652 657
18. P.K. Selbo, A. Weyergang, A. Hogset, O.J. Norum, M.B. Berstad, M. Vikdal, and K. Berg Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules J. Control. Release 148 2010 2 12
19. A. Bonsted, B.O. Engesaeter, A. Hogset, G.M. Maelandsmo, L. Prasmickaite, O. Kaalhus, and K. Berg Transgene expression is increased by photochemically mediated transduction of polycation-complexed adenoviruses Gene Ther. 11 2004 152 160
20. M. Hellum, A. Hogset, B.O. Engesaeter, L. Prasmickaite, T. Stokke, C. Wheeler, and K. Berg Photochemically enhanced gene delivery with cationic lipid formulations Photochem. Photobiol. Sci. 2 2003 407 411
21. A. Dietze, A. Bonsted, A. Hogset, and K. Berg Photochemical internalization enhances the cytotoxic effect of the protein toxin gelonin and transgene expression in sarcoma cells Photochem. Photobiol. 78 2003 283 289
22. A. Bonsted, B.O. Engesaeter, A. Hogset, and K. Berg Photochemically enhanced adenoviral transduction in a multicellular environment Photochem. Photobiol. Sci. 5 2006 411 421
23. K. Berg, A. Dietze, O. Kaalhus, and A. Hogset Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin Clin. Cancer Res. 11 2005 8476 8485
24. K. Berg, S. Nordstrand, P.K. Selbo, D.T. Tran, E. ngell-Petersen, and A. Hogset Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization Photochem. Photobiol. Sci. 10 2011 1637 1651
25. K. Berg, A. Hogset, L. Prasmickaite, A. Weyergang, A. Bonsted, A. Dietze, P.J. Lou, S.G. Bown, O.J. Norum, H.M.T. Mollergård, and P.K. Selbo Photochemical internalization (PCI): a novel technology for activation of endocytosed therapeutic agents Med. Laser Appl. 2006 239 250
26. P.K. Selbo, A. Weyergang, A. Bonsted, S.G. Bown, and K. Berg Photochemical internalization of therapeutic macromolecular agents: a novel strategy to kill multidrug-resistant cancer cells J. Pharmacol. Exp. Ther. 319 2006 604 612
27. A. Weyergang, P.K. Selbo, and K. Berg Y1068 phosphorylation is the most sensitive target of disulfonated tetraphenylporphyrin-based photodynamic therapy on epidermal growth factor receptor Biochem. Pharmacol. 74 2007 226 235
28. P.K. Selbo, K. Sandvig, V. Kirveliene, and K. Berg Release of gelonin from endosomes and lysosomes to cytosol by photochemical internalization Biochim. Biophys. Acta 1475 2000 307 313
29. A. Hogset, L. Prasmickaite, M. Hellum, B.O. Engesaeter, V.M. Olsen, T.E. Tjelle, C.J. Wheeler, and K. Berg Photochemical transfection: a technology for efficient light-directed gene delivery Somat. Cell Mol. Genet. 27 2002 97 113
30. L.Y. Shiu, C.H. Liang, Y.S. Huang, H.M. Sheu, and K.W. Kuo Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu Cell Biol. Toxicol. 24 2008 1 10
31. P. Rizzo, H. Miao, G. D'Souza, C. Osipo, L.L. Song, J. Yun, H. Zhao, J. Mascarenhas, D. Wyatt, G. Antico, L. Hao, K. Yao, P. Rajan, C. Hicks, K. Siziopikou, S. Selvaggi, A. Bashir, D. Bhandari, A. Marchese, U. Lendahl, J.Z. Qin, D.A. Tonetti, K. Albain, B.J. Nickoloff, and L. Miele Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches Cancer Res. 68 2008 5226 5235
32. P.H. Tseng, Y.C. Wang, S.C. Weng, J.R. Weng, C.S. Chen, R.W. Brueggemeier, C.L. Shapiro, C.Y. Chen, S.E. Dunn, M. Pollak, and C.S. Chen Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor Mol. Pharmacol. 70 2006 1534 1541
33. J. Moan, and K. Berg The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen Photochem. Photobiol. 53 1991 549 553
34. A.W. Girotti Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms J. Photochem. Photobiol. B 63 2001 103 113
35. L.J. Pike Lipid rafts: bringing order to chaos J. Lipid Res. 44 2003 655 667
36. L.J. Pike Growth factor receptors, lipid rafts and caveolae: an evolving story Biochim. Biophys. Acta 1746 2005 260 273
37. O.O. Glebov, N.A. Bright, and B.J. Nichols Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells Nat. Cell Biol. 8 2006 46 54
38. G.J. Doherty, and H.T. McMahon Mechanisms of endocytosis Annu. Rev. Biochem. 78 2009 857 902 (pp. 857-902)
39. W. Zhu, B. Okollie, and D. Artemov Controlled internalization of Her-2/ neu receptors by cross-linking for targeted delivery Cancer Biol. Ther. 6 2007 1960 1966
40. S. Bhattacharyya, R. Bhattacharya, S. Curley, M.A. McNiven, and P. Mukherjee Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis Proc. Natl. Acad. Sci. U. S. A. 107 2010 14541 14546
41. D.S. Alberts, H.S. Chen, R. Liu, K.J. Himmelstein, M. Mayersohn, D. Perrier, J. Gross, T. Moon, A. Broughton, and S.E. Salmon Bleomycin pharmacokinetics in man. I. Intravenous administration Cancer Chemother. Pharmacol. 1 1978 177 181
42. M. Andrzejak, M. Santiago, and D. Kessel Effects of endosomal photodamage on membrane recycling and endocytosis Photochem. Photobiol. 87 2011 699 706
43. D. Kessel, M. Price, J. Caruso, and J. Reiners Jr. Effects of photodynamic therapy on the endocytic pathway Photochem. Photobiol. Sci. 10 2011 491 498
44. D. Kessel Inhibition of endocytic processes by photodynamic therapy Lasers Surg. Med. 43 2011 542 547
45. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng Photodynamic therapy J. Natl. Cancer Inst. 90 1998 889 905
46. J.S. Dysart, and M.S. Patterson Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro Phys. Med. Biol. 50 2005 2597 2616
47. M.J. Niedre, A.J. Secord, M.S. Patterson, and B.C. Wilson In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy Cancer Res. 63 2003 7986 7994
48. S.R. Wood, J.A. Holroyd, and S.B. Brown The subcellular localization of Zn(II) phthalocyanines and their redistribution on exposure to light Photochem. Photobiol. 65 1997 397 402
49. G.H. Rodal, S.K. Rodal, J. Moan, and K. Berg Liposome-bound Zn (II)-phthalocyanine. Mechanisms for cellular uptake and photosensitization J. Photochem. Photobiol. B 45 1998 150 159
50. K. Berg, K. Madslien, J.C. Bommer, R. Oftebro, J.W. Winkelman, and J. Moan Light induced relocalization of sulfonated meso-tetraphenylporphines in NHIK 3025 cells and effects of dose fractionation Photochem. Photobiol. 53 1991 203 210
51. P. Nagy, G. Vereb, Z. Sebestyen, G. Horvath, S.J. Lockett, S. Damjanovich, J.W. Park, T.M. Jovin, and J. Szollosi Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2 J. Cell Sci. 115 2002 4251 4262
52. P. Nagy, A. Jenei, A.K. Kirsch, J. Szollosi, S. Damjanovich, and T.M. Jovin Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy J. Cell Sci. 112 1999 1733 1741
53. D.V. Sakharov, E.D. Elstak, B. Chernyak, and K.W. Wirtz Prolonged lipid oxidation after photodynamic treatment. Study with oxidation-sensitive probe C11-BODIPY581/591 FEBS Lett. 579 2005 1255 1260
54. D.J. Barr, A.G. Ostermeyer-Fay, R.A. Matundan, and D.A. Brown Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells J. Cell Sci. 121 2008 3155 3166
55. Y. Lu, X. Zi, Y. Zhao, D. Mascarenhas, and M. Pollak Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin) J. Natl. Cancer Inst. 93 2001 1852 1857
56. S.A. Price-Schiavi, S. Jepson, P. Li, M. Arango, P.S. Rudland, L. Yee, and K.L. Carraway Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance Int. J. Cancer 99 2002 783 791
57. P. Nagy, E. Friedlander, M. Tanner, A.I. Kapanen, K.L. Carraway, J. Isola, and T.M. Jovin Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line Cancer Res. 65 2005 473 482
58. R. Nahta, and F.J. Esteva HER2 therapy: molecular mechanisms of trastuzumab resistance Breast Cancer Res. 8 2006 215